GSA Capital Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,642
Closed -$322K 2047
2023
Q2
$322K Buy
+7,642
New +$309K 0.03% 1011
2023
Q1
Sell
-16,222
Closed -$595K 2043
2022
Q4
$595K Buy
+16,222
New +$641K 0.07% 494
2020
Q4
Sell
-13,394
Closed -$712K 1698
2020
Q3
$712K Buy
+13,394
New +$798K 0.12% 226
2020
Q1
Sell
-23,907
Closed -$1.42M 1680
2019
Q4
$1.42M Buy
23,907
+3,166
+15% +$170K 0.17% 83
2019
Q3
$1.1M Sell
20,741
-812
-4% -$41.7K 0.15% 127
2019
Q2
$1.1M Sell
21,553
-13,705
-39% -$638K 0.12% 193
2019
Q1
$1.82M Buy
35,258
+8,306
+31% +$403K 0.18% 80
2018
Q4
$1.06M Buy
+26,952
New +$1.25M 0.12% 192
2017
Q4
Sell
-41,160
Closed -$2.15M 1886
2017
Q3
$2.15M Sell
41,160
-23,604
-36% -$1.32M 0.15% 130
2017
Q2
$3.79M Sell
64,764
-30,151
-32% -$1.57M 0.25% 29
2017
Q1
$4.35M Buy
94,915
+15,335
+19% +$763K 0.23% 31
2016
Q4
$4.19M Sell
79,580
-23,327
-23% -$1.13M 0.25% 26
2016
Q3
$4.59M Buy
102,907
+18,911
+23% +$820K 0.25% 28
2016
Q2
$3.2M Sell
83,996
-9,935
-11% -$436K 0.18% 85
2016
Q1
$3.87M Buy
93,931
+6,765
+8% +$279K 0.25% 26
2015
Q4
$4.23M Buy
87,166
+14,204
+19% +$632K 0.21% 48
2015
Q3
$2.92M Buy
72,962
+31,067
+74% +$1.36M 0.14% 126
2015
Q2
$1.68M Sell
41,895
-9,502
-18% -$328K 0.06% 510
2015
Q1
$1.68M Buy
+51,397
New +$1.42M 0.07% 457

Other funds holding SYNH

GSA Capital Partners's SYNH Position: Q3 2023 in Review

GSA Capital Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 7,642 shares — an estimated $322K sold.

GSA Capital Partners first reported a position in SYNH in Q1 2015 and held it in 19 quarters. The position peaked at $4.59M in Q3 2016. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • GSA Capital Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • GSA Capital Partners sold 7,642 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $322K.
  • GSA Capital Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 19 quarters.
  • GSA Capital Partners's Syneos Health, Inc. Class A Common Stock position peaked at $4.59M in Q3 2016.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.